Siemens Healthineers is reportedly planning to exit its investment in cancer care network American Oncology Institute (AOI) in a deal that could value the hospital chain between ₹1,500 crore and ₹2,000 crore. According to industry sources, the German medical technology major has initiated discussions with potential investors and buyers as part of its proposed divestment strategy. The company has reportedly appointed advisory firm Alvarez & Marsal to manage the transaction process.
American Oncology Institute headquartered in Hyderabad, operates a network of specialised cancer care centres across India and South Asia. The chain has focused on expanding access to oncology services through advanced cancer treatment infrastructure, radiation therapy, diagnostics and multidisciplinary cancer care programmes. Healthcare industry observers say the possible exit reflects a broader trend among global healthcare and technology firms to optimise portfolios and monetise investments amid rising consolidation in India’s healthcare sector.
AOI has emerged as a significant player in India’s organised oncology market over the past few years benefiting from growing cancer incidence, increasing healthcare awareness, rising insurance penetration, and expanding demand for specialised cancer treatment services. Experts note that India’s oncology sector is witnessing strong investor interest due to increasing burden of cancer cases and rising demand for advanced radiation therapy, precision oncology and specialised cancer hospitals.
The potential transaction is also expected to attract interest from private equity firms, strategic healthcare investors and hospital operators seeking to strengthen their oncology footprint in India’s rapidly growing healthcare market. Industry analysts say cancer care remains one of the fastest-growing segments within India’s healthcare ecosystem, driven by increasing urbanisation, ageing population trends, lifestyle-related diseases and improved diagnostic capabilities.
The development comes at a time when India’s healthcare sector is experiencing significant merger and acquisition activity, particularly in speciality healthcare verticals such as oncology, fertility care, nephrology and tertiary care services. Healthcare experts believe specialised care chains such as AOI have become increasingly valuable because oncology treatment requires high-end medical infrastructure, advanced equipment, specialist doctors and long-term patient management systems. While Siemens Healthineers has not officially commented on the reported exit plans, market observers believe the move may align with the company’s broader global capital allocation and strategic investment priorities.